Pharmacological, pharmacokinetic and clinical profile of meloxicam

被引：12
作者：
Degner, F
Turck, D
Pairet, M
机构：
[1] Boehringer Ingelheim KG, D-55216 Ingelheim, Germany
[2] Dr Karl Thomae GmbH, D-7950 Biberach, Germany
来源：
DRUGS OF TODAY | 1997年 / 33卷 / 10期
关键词：
D O I：
10.1358/dot.1997.33.10.451138
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：739 / 758
页数：20
相关论文
共 77 条
[1]  
ACERBI D, 1988, INT J CLIN PHARM RES, V8, P175
[2]   Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica [J].
Auvinet, B ;
Ziller, R ;
Appelboom, T ;
Velicitat, P .
CLINICAL THERAPEUTICS, 1995, 17 (06) :1078-1090
[3]   Effects of meloxicam compared to acetylsalicyclic acid in human articular chondrocytes [J].
Bassleer, C ;
Magotteaux, J ;
Geenen, V ;
Malaise, M .
PHARMACOLOGY, 1997, 54 (01) :49-56
[4]  
Bevis PJR, 1996, BRIT J RHEUMATOL, V35, P56
[5]  
Blanco Francisco J., 1997, Arthritis and Rheumatism, V40, pS88
[6]  
BOSCH HC, 1996, RHEUMATOL EUR S1, V25, P431
[7]   Meloxicam pharmacokinetics in renal impairment [J].
BoultonJones, JM ;
Geddes, CG ;
Heinzel, G ;
Turck, D ;
Nehmiz, G ;
Bevis, PJR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (01) :35-40
[8]   Pharmacokinetics of meloxicam in patients with hepatic cirrhosis in comparison with healthy volunteers [J].
Busch, U ;
Heinzel, G ;
Narjes, H ;
Nehmiz, G ;
Turck, D ;
Krimmer, J ;
Rosch, W .
CLINICAL DRUG INVESTIGATION, 1996, 11 (02) :97-107
[9]  
BUSCH U, 1995, EUR J CLIN PHARMACOL, V48, P269
[10]  
BUSCH U, UNPUB DRUG METAB DIS
12345678